Vaccine makers have warned US officials that temporarily scrapping patents for Covid-19 shots would risk handing novel technology to China and Russia, according to people familiar with the talks.
As industry lobbying has escalated in Washington, companies have warned in private meetings with US trade and White House officials that giving up the intellectual property rights could allow China and Russia to exploit platforms such as mRNA, which could be used for other vaccines or even therapeutics for conditions such as cancer and heart problems in the future.
J&J, Pfizer, Moderna and Novavax did not respond to requests for comment.
您已阅读13%（637字），剩余87%（4189字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。